153 related articles for article (PubMed ID: 28220557)
1. Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands.
Traoré M; Gignac M; Doan ND; Hof F; Lubell WD
J Pept Sci; 2017 Apr; 23(4):266-271. PubMed ID: 28220557
[TBL] [Abstract][Full Text] [Related]
2. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
Chingle R; Proulx C; Lubell WD
Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
[TBL] [Abstract][Full Text] [Related]
3. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).
Simhadri C; Daze KD; Douglas SF; Quon TT; Dev A; Gignac MC; Peng F; Heller M; Boulanger MJ; Wulff JE; Hof F
J Med Chem; 2014 Apr; 57(7):2874-83. PubMed ID: 24625057
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis.
Sabatino D; Proulx C; Pohankova P; Ong H; Lubell WD
J Am Chem Soc; 2011 Aug; 133(32):12493-506. PubMed ID: 21692501
[TBL] [Abstract][Full Text] [Related]
5. Aza-amino acid scanning of secondary structure suited for solid-phase peptide synthesis with fmoc chemistry and aza-amino acids with heteroatomic side chains.
Boeglin D; Lubell WD
J Comb Chem; 2005; 7(6):864-78. PubMed ID: 16283795
[TBL] [Abstract][Full Text] [Related]
6. Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-aza(1)-dipeptides in peptide synthesis.
Melendez RE; Lubell WD
J Am Chem Soc; 2004 Jun; 126(21):6759-64. PubMed ID: 15161304
[TBL] [Abstract][Full Text] [Related]
7. Azapeptides and their therapeutic potential.
Proulx C; Sabatino D; Hopewell R; Spiegel J; García Ramos Y; Lubell WD
Future Med Chem; 2011 Jul; 3(9):1139-64. PubMed ID: 21806378
[TBL] [Abstract][Full Text] [Related]
8. Aza-Amino Acids Disrupt β-Sheet Secondary Structures.
McMechen MA; Willis EL; Gourville PC; Proulx C
Molecules; 2019 May; 24(10):. PubMed ID: 31109055
[TBL] [Abstract][Full Text] [Related]
9. Probing opioid receptor interactions with azacycloalkane amino acids. Synthesis of a potent and selective ORL1 antagonist.
Halab L; Becker JA; Darula Z; Tourwé D; Kieffer BL; Simonin F; Lubell WD
J Med Chem; 2002 Nov; 45(24):5353-7. PubMed ID: 12431062
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of the first all-aza analogue of a biologically active peptide.
Gante J; Krug M; Lauterbach G; Weitzel R; Hiller W
J Pept Sci; 1995; 1(3):201-6. PubMed ID: 9222997
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
[TBL] [Abstract][Full Text] [Related]
12. Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain.
Kurian LA; Silva TA; Sabatino D
Bioorg Med Chem Lett; 2014 Sep; 24(17):4176-80. PubMed ID: 25127870
[TBL] [Abstract][Full Text] [Related]
13. Rational Adaptation of L3MBTL1 Inhibitors to Create Small-Molecule Cbx7 Antagonists.
Simhadri C; Daze KD; Douglas SF; Milosevich N; Monjas L; Dev A; Brown TM; Hirsch AKH; Wulff JE; Hof F
ChemMedChem; 2019 Aug; 14(15):1444-1456. PubMed ID: 31254321
[TBL] [Abstract][Full Text] [Related]
14. Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine.
Traoré M; Doan ND; Lubell WD
Org Lett; 2014 Jul; 16(13):3588-91. PubMed ID: 24959890
[TBL] [Abstract][Full Text] [Related]
15. Solid phase submonomer azapeptide synthesis.
Bowles M; Proulx C
Methods Enzymol; 2021; 656():169-190. PubMed ID: 34325786
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor.
Boeglin D; Hamdan FF; Melendez RE; Cluzeau J; Laperriere A; Héroux M; Bouvier M; Lubell WD
J Med Chem; 2007 Mar; 50(6):1401-8. PubMed ID: 17319653
[TBL] [Abstract][Full Text] [Related]
17. Exploring side-chain diversity by submonomer solid-phase aza-peptide synthesis.
Sabatino D; Proulx C; Klocek S; Bourguet CB; Boeglin D; Ong H; Lubell WD
Org Lett; 2009 Aug; 11(16):3650-3. PubMed ID: 19606817
[TBL] [Abstract][Full Text] [Related]
18. Cyclic aza-peptide integrin ligand synthesis and biological activity.
Spiegel J; Mas-Moruno C; Kessler H; Lubell WD
J Org Chem; 2012 Jun; 77(12):5271-8. PubMed ID: 22582818
[TBL] [Abstract][Full Text] [Related]
19. Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7.
Tabet S; Douglas SF; Daze KD; Garnett GA; Allen KJ; Abrioux EM; Quon TT; Wulff JE; Hof F
Bioorg Med Chem; 2013 Nov; 21(22):7004-10. PubMed ID: 24100156
[TBL] [Abstract][Full Text] [Related]
20. Introducing sequential aza-amino acids units induces repeated β-turns and helical conformations in peptides.
Tonali N; Correia I; Lesma J; Bernadat G; Ongeri S; Lequin O
Org Biomol Chem; 2020 May; 18(18):3452-3458. PubMed ID: 32091060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
